News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rodino-Klapac Louise
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/10/2023 |
4
| Rodino-Klapac Louise (Head of R&D, CSO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 912 shares
@ $153.19, valued at
$139.7k
|
|
| 03/08/2023 |
4
| Rodino-Klapac Louise (Head of R&D, CSO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,134 shares
@ $157.21, valued at
$178.3k
Granted 4,500 shares
@ $0
Granted 27,000 options to buy
@ $155.99, valued at
$4.2M
|
|
| 03/03/2023 |
4
| Rodino-Klapac Louise (Head of R&D, CSO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 522 shares
@ $147.57, valued at
$77k
|
|
| 11/21/2022 |
4
| Rodino-Klapac Louise (Head of R&D, CSO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,211 shares
@ $108.52, valued at
$457k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2021 |
4
| Rodino-Klapac Louise (Head of R&D, CSO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Bought 3,780 shares
@ $79.33, valued at
$299.9k
|
|
| 11/17/2021 |
4
| Rodino-Klapac Louise (Chief Scientific Officer) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 03/10/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/05/2021 |
4
| Rodino-Klapac Louise (Chief Scientific Officer) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 60,000 options to buy
@ $87.11, valued at
$5.2M
|
|
| 12/14/2020 |
4
| Rodino-Klapac Louise (Chief Scientific Officer) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $169.54, valued at
$4.2M
|
|
| 12/14/2020 |
3
| Rodino-Klapac Louise (Chief Scientific Officer) has filed a Form 3 on Sarepta Therapeutics, Inc. |
|
|